Chung CH - Search Results

1

Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Lucs A, Saltman B, Chung CH, Steinberg BM, Schwartz DL. Lucs A, et al. Among authors: chung ch. Head Neck. 2013 Feb;35(2):294-306. doi: 10.1002/hed.21975. Epub 2012 Jan 27. Head Neck. 2013. PMID: 22287320 Free PMC article. Review.

2

Clinical applications of genomics in head and neck cancer.

Chung CH, Levy S, Yarbrough WG. Chung CH, et al. Head Neck. 2006 Apr;28(4):360-8. doi: 10.1002/hed.20323. Head Neck. 2006. PMID: 16284976 Review.

3

Update on molecular diagnostic tests in head and neck cancer.

Palka KT, Slebos RJ, Chung CH. Palka KT, et al. Among authors: chung ch. Semin Oncol. 2008 Jun;35(3):198-210. doi: 10.1053/j.seminoncol.2008.03.002. Semin Oncol. 2008. PMID: 18544435 Free PMC article. Review.

4

Evolution of clinical trials in head and neck cancer.

Yang ES, Murphy BM, Chung CH, Netterville JL, Burkey BB, Gilbert J, Yarbrough WG, Sinard R, Cmelak AJ. Yang ES, et al. Among authors: chung ch. Crit Rev Oncol Hematol. 2009 Jul;71(1):29-42. doi: 10.1016/j.critrevonc.2008.09.015. Epub 2008 Nov 7. Crit Rev Oncol Hematol. 2009. PMID: 18996026 Review.

5

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.

Chung CH, Pohlmann PR, Rothenberg ML, Burkey BB, Parker J, Palka K, Aulino J, Puzanov I, Murphy B. Chung CH, et al. Head Neck. 2011 Dec;33(12):1804-8. doi: 10.1002/hed.21478. Epub 2010 Jul 22. Head Neck. 2011. PMID: 20652976 Free PMC article.

6

Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation.

Howard JD, Lu B, Chung CH. Howard JD, et al. Among authors: chung ch. Oral Oncol. 2012 Jan;48(1):10-7. doi: 10.1016/j.oraloncology.2011.09.013. Epub 2011 Oct 22. Oral Oncol. 2012. PMID: 22020057 Review.

7

Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.

Chung CH, Schwartz DL. Chung CH, et al. Otolaryngol Clin North Am. 2012 Aug;45(4):795-806. doi: 10.1016/j.otc.2012.04.002. Epub 2012 May 30. Otolaryngol Clin North Am. 2012. PMID: 22793853 Review.

8

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma.

Markovic A, Chung CH. Markovic A, et al. Among authors: chung ch. Expert Rev Anticancer Ther. 2012 Sep;12(9):1149-59. doi: 10.1586/era.12.91. Expert Rev Anticancer Ther. 2012. PMID: 23098115 Free PMC article. Review.

9

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.

Li R, Faden DL, Fakhry C, Langelier C, Jiao Y, Wang Y, Wilkerson MD, Pedamallu CS, Old M, Lang J, Loyo M, Ahn SM, Tan M, Gooi Z, Chan J, Richmon J, Wood LD, Hruban RH, Bishop J, Westra WH, Chung CH, Califano J, Gourin CG, Bettegowda C, Meyerson M, Papadopoulos N, Kinzler KW, Vogelstein B, DeRisi JL, Koch WM, Agrawal N. Li R, et al. Among authors: chung ch. Head Neck. 2015 Nov;37(11):1642-9. doi: 10.1002/hed.23807. Epub 2014 Aug 23. Head Neck. 2015. PMID: 24954188 Free PMC article.

10

Novel targets in head and neck cancer: should we be optimistic?

Krigsfeld GS, Chung CH. Krigsfeld GS, et al. Among authors: chung ch. Clin Cancer Res. 2015 Feb 1;21(3):495-7. doi: 10.1158/1078-0432.CCR-14-1776. Epub 2014 Oct 9. Clin Cancer Res. 2015. PMID: 25301846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,691 results

Search Page